Botham, R. C., Hallows, W. C., Reddy, C., Dellas, N., Homan, D., Lao, J., … Silverman, A. P. (2021). Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease. In Molecular Genetics and Metabolism (Vol. 132, pp. S20–S21). Elsevier BV. https://doi.org/10.1016/j.ymgme.2020.12.028

Botham, Rachel C., William C. Hallows, Charu Reddy, Nikki Dellas, David Homan, Jessica Lao, Cynthia Zhu, et al. “Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease.” In Molecular Genetics and Metabolism, 132:S20–21. Elsevier BV, 2021. https://doi.org/10.1016/j.ymgme.2020.12.028.

Botham RC, Hallows WC, Reddy C, Dellas N, Homan D, Lao J, et al. Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease. In: Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S20–1.

Botham, Rachel C., et al. “Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease.” Molecular Genetics and Metabolism, vol. 132, no. 2, Elsevier BV, 2021, pp. S20–21. Crossref, doi:10.1016/j.ymgme.2020.12.028.

Botham RC, Hallows WC, Reddy C, Dellas N, Homan D, Lao J, Zhu C, Chng C, Sero A, Miller M, Choi SJ, Sun B, McCluskie K, Huisman G, Silverman AP. Engineering α-glucosidase to improve protein stability and cellular uptake for the potential treatment of Pompe disease. Molecular Genetics and Metabolism. Elsevier BV; 2021. p. S20–S21.